- Issuer
- Defiance
- Inception Date
- Feb 3, 2026
- Category
- Leveraged Equities
- Leveraged
- 2x
- Index Tracked
- No Index (Active)
- Asset Class
- Equity
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
MRNX Performance Chart
Loading charts...
Returns By Period
Defiance Daily Target 2X Long MRNA ETF
- 1D
- 20.68%
- 1M
- 148.37%
- 6M
- —
- YTD
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 0.00%
- 1M
- -0.93%
- 6M
- 9.11%
- YTD
- 9.32%
- 1Y
- 19.17%
- 3Y*
- 18.87%
- 5Y*
- 11.45%
- 10Y*
- 13.53%
MRNX Monthly Returns History
Based on dividend-adjusted daily data since Feb 4, 2026, MRNX's average daily return is +1.30%, while the average monthly return is +24.60%. At this rate, an investment would double in approximately 0.3 years.
Historically, 67% of months were positive and 33% were negative. The best month was Jun 2026 with a return of +103.0%, while the worst month was Apr 2026 at -21.0%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 2 months.
On a daily basis, MRNX closed higher 50% of trading days. The best single day was Mar 4, 2026 with a return of +32.2%, while the worst single day was Jun 5, 2026 at -15.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 50.63% | -15.31% | -21.00% | 1.14% | 103.01% | 29.14% | 167.25% |
Benchmark Metrics
Defiance Daily Target 2X Long MRNA ETF has an annualized alpha of 1187.11%, beta of 3.50, and R2 of 0.15 versus S&P 500 Index. Calculated based on daily prices since February 04, 2026.
- This ETF tended to rise when S&P 500 Index fell (downside capture of -19034.92%), but participation in market rallies was also limited (-51.02%) - a profile typical of counter-cyclical assets.
- R2 of 0.15 means this ETF moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 1,187.11%
- Beta
- 3.50
- R²
- 0.15
- Upside Capture
- -51.02%
- Downside Capture
- -19,034.92%
Expense Ratio
MRNX has a high expense ratio of 1.31%, indicating above-average management fees.
Return for Risk
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Defiance Daily Target 2X Long MRNA ETF (MRNX) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MRNX | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | — | 1.29 | — |
| Calmar ratioReturn relative to maximum drawdown | — | 2.23 | — |
| Martin ratioReturn relative to average drawdown | — | 9.69 | — |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Defiance Daily Target 2X Long MRNA ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Defiance Daily Target 2X Long MRNA ETF was 45.00%, occurring on Jun 10, 2026. Recovery took 6 trading sessions.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -45.00%Jun 2026 | 3mo 7d | 8d | 3mo 15dMar 2026 - Jun 2026 |
2026 correction2026 | -14.06%Jun 2026 | 0s | 4d | 4dJun 2026 - Jun 2026 |
2026 correction2026 | -13.78%Feb 2026 | 8d | 5d | 13dFeb 2026 - Feb 2026 |
2026 correction2026 | -13.64%Mar 2026 | 1d | 1d | 2dMar 2026 - Mar 2026 |
Drawdown Indicators
| MRNX | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.00% | -56.78% | +11.78% |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.10% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | 0.00% | -1.66% | +1.66% |
Average DrawdownAverage peak-to-trough decline | -21.30% | -10.71% | -10.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 2.09% | — |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Build a portfolio with MRNX
Add Defiance Daily Target 2X Long MRNA ETF to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with MRNX